- Home
- XPON vs HSCS Comparison
XPON vs HSCS Comparison
Compare XPON & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- HSCS
- Stock Information
- Founded
- XPON 2016
- HSCS 2007
- Country
- XPON United States
- HSCS United States
- Employees
- XPON N/A
- HSCS N/A
- Industry
- XPON Electronic Components
- HSCS Medical Specialities
- Sector
- XPON Technology
- HSCS Health Care
- Exchange
- XPON Nasdaq
- HSCS Nasdaq
- Market Cap
- XPON 3.2M
- HSCS 3.7M
- IPO Year
- XPON 2022
- HSCS 2022
- Fundamental
- Price
- XPON $0.83
- HSCS $3.74
- Analyst Decision
- XPON
- HSCS Strong Buy
- Analyst Count
- XPON 0
- HSCS 2
- Target Price
- XPON N/A
- HSCS $13.00
- AVG Volume (30 Days)
- XPON 46.9K
- HSCS 68.9K
- Earning Date
- XPON 08-13-2025
- HSCS 07-28-2025
- Dividend Yield
- XPON N/A
- HSCS N/A
- EPS Growth
- XPON N/A
- HSCS N/A
- EPS
- XPON N/A
- HSCS N/A
- Revenue
- XPON $6,702,411.00
- HSCS N/A
- Revenue This Year
- XPON $61.26
- HSCS N/A
- Revenue Next Year
- XPON N/A
- HSCS N/A
- P/E Ratio
- XPON N/A
- HSCS N/A
- Revenue Growth
- XPON 23.07
- HSCS 261.17
- 52 Week Low
- XPON $0.60
- HSCS $2.36
- 52 Week High
- XPON $120.00
- HSCS $5.44
- Technical
- Relative Strength Index (RSI)
- XPON 43.08
- HSCS 52.06
- Support Level
- XPON $0.81
- HSCS $3.66
- Resistance Level
- XPON $0.97
- HSCS $4.03
- Average True Range (ATR)
- XPON 0.08
- HSCS 0.30
- MACD
- XPON -0.01
- HSCS 0.01
- Stochastic Oscillator
- XPON 18.57
- HSCS 41.11
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.